Concepedia

Naomi Kitamoto

NK

Statistics

Publications

4

Citations

615

H-Index

4

Active since

1996

Affiliations

Takeda (Japan)(Current)

Pharmacology Research Institute

Naomi Kitamoto is an author at Takeda (Japan) specializing in new antifungal agents, antifungal therapy, and fungal infections.

Publications per year

1996–2020

4

Publications

4

The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice

Aisha Yesbolatova, Yuichiro Saito, Naomi Kitamoto et al. · Nature Communications · 2020 · 574 citations · Full text

, , +7

In Vitro and In Vivo Antifungal Activities of TAK-456, a Novel Oral Triazole with a Broad Antifungal Spectrum

Noboru Tsuchimori, Ryogo HAYASHI, Naomi Kitamoto et al. · Antimicrobial Agents and Chemotherapy · 2002 · 16 citations · Full text

, , +15

Streptococcus pneumoniae in the nasal cavity of mice causes lower respiratory tract infection after airway obstruction

Yuji Iizawa, Naomi Kitamoto, Kimiko Hiroe et al. · Journal of Medical Microbiology · 1996 · 14 citations

, , +15

Efficacy of TAK-457, a Novel Intravenous Triazole, against Invasive Pulmonary Aspergillosis in Neutropenic Mice

Ryogo HAYASHI, Naomi Kitamoto, Yuji Iizawa et al. · Antimicrobial Agents and Chemotherapy · 2002 · 11 citations · Full text

, , +17

1–4 of 4